HARVEY SANDERS: Open Payments
NPI 1215979257 · WAYNESBORO, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$243 in 14 payments from 9 companies in 2025. Trend: 2023 $272 · 2024 $283 · 2025 $243
Food & beverage: $243
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $50 |
| Abbott Laboratories | 2 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $29 |
| ABBVIE INC. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $17 |
| Amgen Inc. | 1 | $16 |
| Merck Sharp & Dohme LLC | 1 | $14 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: Wegovy, CAPLYTA, FREESTYLE LIBRE 3, Kerendia, VRAYLAR, Veozah, OTEZLA, GARDASIL 9.
Industry payments across GA — which companies pay providers there.
